Overview

Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

Status:
Completed
Trial end date:
2021-02-22
Target enrollment:
Participant gender:
Summary
This phase II randomized trial studies how well bupropion hydrochloride works in improving sexual desire in women with breast or gynecological cancer. Bupropion hydrochloride may work by boosting sexual desire, energy, or motivation without causing intolerable or undesirable side effects.
Phase:
Phase 2
Details
Lead Sponsor:
NRG Oncology
Collaborator:
National Cancer Institute (NCI)
Treatments:
Bupropion